| Literature DB >> 27833904 |
Maria Helena Palma Sircili1, Tania Sartori Sanchez Bachega2, Guiomar Madureira2, Larissa Gomes2, Berenice Bilharinho Mendonca2, Francisco Tibor Dénes3.
Abstract
PURPOSE: Genital reconstruction in female patients with virilizing congenital adrenal hyperplasia (CAH) is very challenging. Our aim was to evaluate the techniques employed to treat complications after failure of primary urogenital sinus (UGS) surgery, as well as the result of these reoperations. PATIENTS AND METHODS: Twenty girls with virilizing CAH who were previously submitted to genitoplasty in our service and elsewhere had recurrent UGS stenosis and vaginal introitus stenosis that required surgical treatment. The main symptoms were recurrent urinary tract infection (UTI) in nine, dyspareunia in six, and hematocolpos in three (two associated with sepsis). The anatomical findings were the persistence of UGS with stenosis in 17 patients and vaginal introitus stenosis in 3. The mean age at procedure was 15.2 years, averaging 13.1 years after the first surgery. The surgical techniques employed were isolated perineal flap in 17 patients and perineal flap with partial mobilization of UGS in 3. The mean follow-up after the procedure was 4.8 years (varying from 1 to 17 years).Entities:
Keywords: congenital adrenal hyperplasia; failed feminizing genitoplasty; follow-up; persistent urogenital sinus; reoperation
Year: 2016 PMID: 27833904 PMCID: PMC5081340 DOI: 10.3389/fped.2016.00118
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.418
Figure 1Patient submitted to previous genitoplasty. (A) Initial aspect with one small perineal orifice, (B) perineal flap incision plus partial UGS mobilization, with catheters in the bladder and vagina, (C) final surgical aspect with separate orifices for urethra and vagina, and (D) late aspect with insertion of vaginal mold.
Clinical data, surgical procedures, and final results of the 20 patients.
| Pt | Symptoms | Physical findings | Age 1st reop (yrs) | Technique 1st reop | Age 2nd reop (yrs) | Technique 2nd reop (yrs) | Age last FU | Separate orifices | Sexual activity |
|---|---|---|---|---|---|---|---|---|---|
| 1 | UTI | UGSS | 7 | YV-PF | 17 | Yes | No | ||
| 2 | None | UGSS | 17 | YV-PF | 20 | Yes | No | ||
| 3 | Menuria | UGSS | 8 | YV-PF | 18 | YV-PF | 23 | No | Yes |
| 4 | UTI | UGSS | 15 | YV-PF | 18 | Yes | No | ||
| 5 | None | UGSS | 13 | YV-PF | 22 | No | Yes | ||
| 6 | UTI + menuria | UGSS | 19 | YV-PF | 21 | YV-PF | 22 | No | No |
| 7 | Menuria | UGSS | 24 | YV-PF | 27 | Yes | Yes | ||
| 8 | UTI + VUR + hematocolpos | UGSS + VIS | 5 | YV-PF | 10 | PMUGS + BM | 12 | Yes | No |
| 9 | Dyspareunia | VIS | 31 | YV-PF | 36 | Yes | Yes | ||
| 10 | None | UGSS | 24 | YV-PF | 26 | Yes | No | ||
| 11 | UTI + dyspareunia | UGSS | 20 | YV-PF | 25 | Yes | Yes | ||
| 12 | Pollakisuria | UGSS | 6 | YV-PF | 10 | YV-PF | 24 | No | No |
| 13 | Hematocolpos | UGSS | 10 | YV-PF | 15 | YV-PF | 22 | Yes | No |
| 14 | Dyspareunia | VIS | 14 | YV-PF | 26 | Yes | Yes | ||
| 15 | Dyspareunia | UGSS | 18 | YV-PF | 21 | Yes | Yes | ||
| 16 | Dyspareunia + urine incontinence | UGSS | 27 | YV-PF | 44 | No | Yes | ||
| 17 | None | UGSS | 21 | YV-PF | 22 | Yes | No | ||
| 18 | UTI + hematocolpos | VIS | 12 | YV-PF + PMUGS | 13 | Yes | No | ||
| 19 | None | UGSS | 14 | YV-PF + PMUGS | 15 | Yes | No | ||
| 20 | UTI | UGSS | 15 | YV-PF + PMUGS | 16 | Yes | No |
Pt, patient; Reop, reoperation; yrs, years; FU, follow-up; UTI, urinary tract infection; VUR, vesico-ureteral reflux; UGSS, urogenital sinus stenosis; VIS, vaginal introitus stenosis; Y-VPF, “Y-V” perineal flap; PMUGS, partial mobilization of the urogenital sinus; BM, buccal mucosa.
.